CharliePeacock

Associate

London + 44.20.7039.5253

Connect:

Share

Charlie Peacock practices corporate law with a focus on M&A, equity capital markets, and private equity and venture capital transactions. She advises public and private companies on a range of domestic and cross-border transactions, including initial public offerings, secondary fund raisings, reorganizations, acquisitions, disposals, and joint ventures.

Charlie has experience working with clients in the real estate, aerospace and defense, hospitality, retail, and health care sectors.

Experience

  • DataBank to acquire zColoJones Day is advising DataBank, a leading provider of enterprise-class colocation, connectivity, and managed services, on its acquisition of zColo, including certain U.S. and European data center assets, from Zayo Group Holdings, Inc.
  • Goldman sold iQ Student Accommodation dorms to Blackstone for £4.66 billionOn May 15, 2020, Jones Day clients Goldman Sachs Merchant Banking Division and the Wellcome Trust completed the sale of iQ Student Accommodation to Blackstone for £4.66 billion (US$5.73 billion), representing the largest ever private real estate transaction in the UK.
  • GCA Altium acquires Stella EOCJones Day advised GCA Altium in the acquisition of Stella EOC, a technology and media investment banking boutique with coverage in the UK and Europe.
  • Sumitomo Heavy Industries invests $46 million into Highview PowerJones Day advised Sumitomo Heavy Industries, Ltd., a technology leader in industrial machinery and environmental and power technologies, in its $46 million investment into Highview Power, a global leader in long-duration energy storage solutions.
  • Barings sells portfolio of light industrial assets on behalf of institutional client to Starwood Capital Group for £200 millionJones Day represented Baring International Investment Limited in connection with the sale of 10 UK urban industrial estates totaling 1.6 million square feet on behalf of an institutional client to Starwood Capital Group for £200 million.
  • CBRE acquires Laxfield CapitalJones Day represented CBRE Global Investors in connection with its acquisition of Laxfield Capital, a real estate debt investment business with £818 million of assets under management in the United Kingdom.
  • Sumitomo Heavy Industries acquires InvertekJones Day advised Sumitomo Heavy Industries, Ltd. in the acquisition of the entire issued share capital of Invertek Drives Ltd.
  • BBA Aviation sells Ontic for $1.365 billionJones Day advised BBA Aviation plc ("BBA") in the sale of its Ontic business to an investment fund affiliated with CVC Capital Partners for $1.365 billion.
  • Loungers completes £185 million IPO on AIMJones Day represented Loungers plc, an operator of 146 cafés, bars, and restaurants across England and Wales, in connection with its £185 million (US$239 million) initial public offering on the Alternative Investment Market of the London Stock Exchange.
  • Faron Pharmaceuticals places €3.1 million of Ordinary Shares on AIMJones Day represented Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company based in Turku, Finland, in connection its €3.1 million (US$3.5 million) placement of Ordinary Shares on the Alternative Investment Market (AIM).
  • True Capital Ltd invests in ThirdEyeJones Day represented True Capital Ltd in connection with its investment in ThirdEye, an AI-driven security platform for retailers.
  • BL Intermediate Holding Company and Henley Investment Management invest in IPSX Group LimitedJones Day represented BL Intermediate Holding Company Limited and Henley Investment Management Limited in connection with their investment in IPSX Group Limited, the world's first regulated securities exchange dedicated to commercial real estate.
  • Independent financial services firm sells One Poultry in LondonJones Day advised an independent financial services firm subsidiary in its sale of a special purpose vehicle which owns One Poultry, London.
  • True Capital Ltd invests in Jump Staff LimitedJones Day represented True Capital Ltd in connection with its seed investment into Jump Staff Limited, an innovative recruitment platform.
  • Huadong Medicine announces £169 million (US$222 million) takeover offer for and acquisition of Sinclair Pharma PlcJones Day advised Huadong Medicine Co. Ltd. ("HMC") and its subsidiary, Huadong Medicine Aesthetics Investment (HongKong) Limited ("Huadong"), on Huadong's takeover offer for and acquisition of Sinclair Pharma Plc with a total value of approximately £169 million (US$222 million).
  • Watchfinder.co.uk sold to RichemontJones Day advised the shareholders of Watchfinder.co.uk Limited, the leading pre-owned premium watch specialist, in connection with the sale of its entire issued share capital to Richemont, the global luxury goods group.
  • Pharmaceutical company obtains injunctive relief to protect commercial information misappropriated by former employeeJones Day advised a pharmaceutical company in relation to urgent injunctive relief and High Court proceedings which led to the delivery up of highly sensitive and very valuable commercial information misappropriated by a former employee following the execution of those proceedings and orders without notice at his address.
  • iQ Student Accommodation acquires Pure Student Living from L1 TreasuryJones Day acted for iQ Student Accommodation in relation to its acquisition of the UK focused Pure Student Living student housing property portfolio and business from LetterOne Treasury.
    • View All
    We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.